Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and tolerability, pharmacokinetics, and
pharmacodynamics of fluticasone furoate/vilanterol (FF/VI) 100/25mcg administered using the
novel dry powder inhaler in children aged 5 to 11 years with persistent asthma.